BNTX Projected Dividend Yield

ADS/BioNTech SE ( NASDAQ : BNTX )

BioNTech SE is a Germany-based clinical-stage biotechnology company. Co. focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. Co. is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules.

12 YEAR PERFORMANCE RESULTS

BNTX Dividend History Detail
BNTX Dividend News
BNTX Competitors News
# of Shares: 0 Closing Price: 120.38 Current Market Value: 0.00 Cost Basis: 0.00 Date Acquired:
Dividend Cash Flow
Year Annual Dividend Dividend Growth # of Shares Annual Dividend Income Yield On Cost %
2023 0.00 0% 0 $ 0.00 0.00%
2024 1.55 0% 0 $ 0.00 1.29%
2025 0.00 0% 0 $ 0.00 1.29%
2026 0.00 0% 0 $ 0.00 1.29%
2027 0.00 0% 0 $ 0.00 1.29%
2028 0.00 0% 0 $ 0.00 1.29%
2029 0.00 0% 0 $ 0.00 1.29%
2030 0.00 0% 0 $ 0.00 1.29%
2031 0.00 0% 0 $ 0.00 1.29%
2032 0.00 0% 0 $ 0.00 1.29%
2033 0.00 0% 0 $ 0.00 1.29%
2034 0.00 0% 0 $ 0.00 1.29%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10yrs would be $ 0.00 with a yield on cost % of 1.29%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection)
0.00
Year
Declaration Date
Ex-Dividend Date
Record Date
Payable Date
Dividend $ Amount
2022
N/A
Jun 02, 2022
Jun 03, 2022
Jun 17, 2022
1.5498
2022 Total:
1.5498
X
Search Dividend Investor